Eye Surgeon
Date of birth: 06.10.1980
Educational information
Student: Faculty of Medicine, Ankara University (1998 – 2004)
Specialisation: S.B. Ankara Training and Research Hospital – specialisation in eye diseases (2005 – 2009)
Career
2020-present: Levent Hospital – SPECIALIST DR.
2018-2020: Globaldr Eye Centre – DR.
2015-2018: European Eye Centre – DR Specialist / Head Physician
2010-2015: Etlik Zübeyde Hanım Gynaecology Education and Research Hospital Centre for Diagnosis, Centre for Diagnosis, Treatment and Training of Premature Retinopathy – Specialist Dr / ROP Instructor
2005-2009: S.B. Ankara Training and Research Hospital 1st Eye Hospital, Ankara – Research Assistant Dr.
Professional memberships: Turkish Ophthalmology Society (TOD), Turkish Republic Ophthalmologists Association (TCOD), Black Sea Ophthalmologists Association (BSOS)
Foreign language: English
Research and publications:
- Articles published in international journals:
A1. Sungur G, Hazirolan D, Hekimoglu E, Kasim R, Duman S.Late-onset Behçet’s disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1325-30.
A2. Sekeroglu MA, Hekimoglu E, Sekeroglu HT. Topical anesthesia for laser treatment of retinopathy of prematurity. Paediatr Anaesth. 2012; 22(12):1224-1225.
A3. Sekeroglu MA, Hekimoglu E, Sekeroglu HT, Arslan U. Alternative methods for the screening of retinopathy of prematurity: binocular indirect ophthalmoscopy vs wide-field digital retinal imaging. Eye (Lond). 2013;27(9):1053-1057.
A4. Sekeroglu MA, Hekimoglu E, Sekeroglu HT, Arslan U. Retinopathy of prematurity: a nationwide survey to evaluate current practices and preferences of ophthalmologists. Eur J Ophthalmol. 2013;23(4):546-552.
A5. Sekeroğlu MA, Sekeroglu HT, Hekimoglu E. Prescription errors in ophthalmology. Indian J Pharmacol. 2013; 45(2):206-207.
A6. Sekeroglu MA, Hekimoglu E, Petricli IS, Tasci Y, Dolen I, Arslan U. The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment. Int Urogynecol J. 2014; 25(11):1479-1482.
A7. Celebi AR, Petricli IS, Hekimoglu E, Demirel N, Bas AY. The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey.Med Sci Monit. 2014 Sep 15;20:1647-53.
A8. Isik DU, Ozcan B, Celik U, Aydemir O, Erdogan KM, Hekimoglu E, Bas AY, Demirel N. A newborn with widespread skin lesions and extremity anomalies. Eur J Pediatr. 2014 Apr;173(4):545-6. Epub 2013 Nov 9
A9. Demirel N, Bas AY, Kavurt S, Celik IH, Yucel H, Turkbay D, Hekimoğlu E, Koc O. . Remifentanil analgesia during laser treatment for retinopathy of prematurity: a practical approach in neonatal intensive care unit.Am J Perinatol. 2014 Nov;31(11):983-6.
A10. Sekeroglu MA, Hekimoglu E, Petricli IS, Karakaya J, Ozcan B, Yucel H, Kavurt AS, Bas AY. Central corneal thickness and intraocular pressure in premature infants. Int Ophthalmol. 2015; 35(6):847-851.
A11. Sekeroglu MA, Hekimoglu E, Ozcan B, Yucel H, Kavurt S, Bas AY, Karakaya J. The effect of gestational age on axial length of the eyes of premature infants. J Clin Anal Med 2015; 6 (suppl 4):459-461
A12. Hekimoglu E, Erol MK, Toslak D, Turgut Coban D, Doğan B, Yucel O. Comparison of Measurement of Central Corneal Thickness with Spectral Domain Optical Coherence Tomography and Standard Ultrasonic Pachymeter in Premature Infants.J Ophthalmol. 2015;2015:129269 Epub 2015 Jul 22
A13. Kale Y, Isik DU, Celik U, Hekimoglu E, Celik IH, Bas AY, Demirel N. Neonatal Marfan syndrome with angle-closure glaucoma, tricuspid and mitral insufficiency. Genet Couns. 2015;26(1):95-8. No abstract available.
A14. Kara C, Petriçli İS, Hekimoğlu E, Akil H, Beyazyildiz Ö.Treatment success of laser therapy for retinopathy of prematurity in referred and non-referred patients.Arq Bras Oftalmol. 2016 Apr;79(2):96-9.
A15. Sekeroglu MA, Hekimoglu E, Tasci Y, Dolen I, Arslan U. Ocular surface changes following oral anticholinergic use for overactive bladder. Cutan Ocul Toxicol. 2016; 35(3):218-221.
A16. Sekeroglu MA, Hekimoglu E, Anayol MA, Tasci Y, Dolen I. An overlooked effect of systemic anticholinergics: Alteration on accommodation amplitude. Int J Ophthalmol. 2016; 9(5):743-745.
A17. Gunay M, Sekeroglu MA, Bardak H, Celik G, Esenulku CM, Hekimoglu E, Bardak Y. Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity. Strabismus. 2016;24(2):84-88.
A18. Şekeroğlu MA, Hekimoğlu E, Çelik Ü, Kale Y, Baş AY. Retinopathy of Prematurity in Triplets.Turk J Ophthalmol. 2016 Jun;46(3):114-117. Epub 2016 Jun 6.
A19. Şekeroğlu MA, Hekimoğlu E, Özcan B, Baş AY, Demirel N, Karakaya J. Bedside Diode Laser Photocoagulation Under Remifentanil Analgesia for Retinopathy of Prematurity: Early Structural Outcomes.Turk J Ophthalmol. 2016 Oct;46(5):209-214. doi: 10.4274/tjo.04557. Epub 2016 Oct 17.
A20. Kara C, Hekimoğlu E, Petriçli İS, Akıl H.J Curr Ophthalmol. 2017 Aug 24;30(1):80 Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity.-84. doi: 10.1016/j.joco.2017.08.007. eCollection 2018 Mar.
- Papers presented at international scientific meetings and published in the conference book:
B1. Sekeroglu MA, Hekimoglu E, Taylan Sekeroglu H, Bas A, Demirel N. Retinopathy of Prematurity: Clinical Features, Risk Factors and Structural Outcomes of Laser Photocoagulation. 2nd World Congress of Pediatric Ophthalmology and Strabismus. 7-9 Eylül 2012, Milano, İtalya, Programme Book, p.45.
B2. Hekimoglu E, Retinopathy of Prematurity, Tiflis Alman Hastanesi, Tiflis, Gürcistan, 3-6 Temmuz 2014
B3. Hekimoglu E, Retinopathy of prematurity bridge, Turkmenistan International Medical Congress, International Eye Bag Centre, Ashgabat, Turkmenistan, 19-23 July 2014.
B4. Sekeroglu MA, Hekimoglu E, Kerimoglu H. Bedside photocoagulation with remifentanil analgesia for retinopathy of prematurity: one-year structural results. ASRS 33rd Annual Meeting. 10-14 July 2015, Vienna, Austria.
- Chapters in national books:
C1. Hekimoglu E, Göz Embriyolojisi. American Academy of Oftalmology 2.kitap Editör. Prof.Dr.Pınar Aydın. Turkish translation
C2. Hekimoglu E, Kornea Topografisi, Section 3-17, Topography Based Rigid Contact Lenses,EditörDoc.Dr. Bahri Aydın Turkish translation
C3. Hekimoglu E, Section 7 Tümörler, The Sankara Nethralaya Atlas of Fundus Fluorescein Angiography 2nd Ed. Pukhraj Rishi (Author), Ekta Rishi (Author), Tarun Sharma (Author), Muna Bhende (Author), Parveen Sen (Author). Turkçe çeviri Editör: Prof.Dr. Irfan Perente Turkish translation
- Articles published in national journals:
D1. Altınbas ŞK, Cenksoy P, Tapisiz ÖL, Hekimoglu E, Gelisen O. Bilateral serous retinal detachment and uterine atony associated with pre-eclampsia. Gynecol Obstet Reprod Med 2012; 18: 97-98.
D2. Kavurt S., Yücel H., Hekimoglu E., Bas AY, Demirel N., Turkbay D. Evaluation of risk factors in patients with retinopathy of prematurity. Journal of Child Health and Diseases 2012; 55: 125-131.
D3. Sekeroglu MA, Hekimoglu E. Unilateral corneal burn after laser treatment of retinopathy of prematurity. Turkey Clinics J Ophthalmol 2013; 22 (4): 275 -277.
D4. Duran S, Hekimoglu E, Altıparmak UE, Sekeroglu MA. Causes and outcomes of anterior segment intraocular lens removal. Glo-Cat 2013; 8 (3): 165-172.
D5. Balcı M, Ozdogan S., Bilir G., Pulat H., Hekimoglu E., Chronic inflammatory event macroscopically mimicking basal cell carcinoma, Journal of Turgut Ozal Medical Center, 2013; 20 (4): 348-350.
D6. Sekeroglu MA, Hekimoglu E, Bas AY, Demirel N. Risk factors for aggressive posterior retinopathy of prematurity, Journal of Retinal Vitreus 2014: 12 (2) 195-198.
D7. Şekeroğlu MA, Hekimoğlu E. A rare complication of laser treatment for retinopathy of prematurity: anterior segment ischaemia and choroidal detachment. Ret-Vit 2014; 22 (2): 153 -156.
D8. Şekeroğlu MA, Petriçli İS, Hekimoğlu E, Özcan B, Kavurt AS. The clinical course of retinopathy of prematurity in preterm quintuplets. Turkey Clinics J Ophthalmol 2014; 23 (4): 240-242.
D9. Şekeroğlu MA, Hekimoğlu E , Baş AY, Demirel N. Aggressive risk factors for premature preterm retinopathy. Ret-Vit 2015; 23 (3): 195 -198.
D10. Sekeroglu MA, Hekimoglu E, Petricli IS, Kavurt AS, Yucel H., Demirel Elmacı N., Arslan U. A significant challenge in retinopathy of prematurity screening: Bell phenomenon. Clinical Journal Turkey Ophthalmol 2015; 24 (4): 227- 231. D11. Şekeroğlu MA, Hekimoğlu E, Çelik G, Günay M, Petriçli İS, Kara C, Karakaya J. Education on premature retinopathy in ophthalmology. Ret-Vit 2015; 23 (3): 241 -245.
- Papers presented at national scientific meetings and published in proceedings:
E1. Şekeroğlu MA, Hekimoğlu E, Arslan U. Efficacy of wide-angle digital imaging systems (RetCam) in screening for retinopathy of prematurity. Oral presentation. TOD 46th National Ophthalmology Congress, Antalya, 17-21 October 2012.
E2. Hekimoğlu E, Şekeroğlu MA. General approaches and practices of ophthalmologists screening and/or treating premature retinopathy. Oral presentation. TOD 46th National Ophthalmology Congress, Antalya, 17-21 October 2012.
E3. Kale Y, Celik Ü, Aydemir Ö, Özcan B, Kavurt AS, Yucel H., Ulubaş Işık D., Hekimoğlu E., Sekeroğlu MA, Baş AY, Demirel N. Renal vein thrombosis and hyphema association. Poster presentation. 20th National Neonatology Congress, Antalya, 15-18 April 2012.
E4. Şekeroğlu MA, Hekimoglu E, Petriçli İS, Taşçı Y, Dölen İ. Ocular surface changes after treatment of overactive bladder syndrome. Poster presentation. TOD 47th National Ophthalmology Congress, 6-10 November 2013, Antalya.
E5. Şekeroğlu MA, Hekimoglu E, Petriçli İS, Baş AY, Demirel N. Alternative methods to general anaesthesia during laser treatment of retinopathy of prematurity: topical anaesthesia and intravenous sedation. Oral presentation. TOD 47th National Ophthalmology Congress, 6-10 November 2013, Antalya.
E6. Hekimoglu E, Sekeroglu MA, Petriçli IS, Kavurt AS, Yücel H., Demirel N. Bell phenomenon occurring during retinopathy of prematurity screening. Poster presentation. TOD 47th National Ophthalmology Congress, 6-10 November 2013, Antalya.
E7. Hekimoglu E, Sekeroğlu MA, Petriçli İS, Taşçı Y, Dölen İ. The effect of oral solifenacin succinate on intraocular pressure and central corneal thickness. Poster presentation. TOD 47th National Ophthalmology Congress, 6-10 November 2013, Antalya.
E8. Petriçli İS, Şekeroğlu MA, Hekimoğlu E, Baş AY, Demirel N. Results of screening examination for retinopathy of prematurity in preterm five-fold infants. Poster presentation. TOD 47th National Ophthalmology Congress, 6-10 November 2013, Antalya.
E9. Hekimoğlu E, Sekeroğlu MA, Çelik G, Günay M, Petriçli İS, Kara C. The results of the survey study on premature retinopathy education of ophthalmologists. Oral presentation. TOD 48th National Congress, 5-9 November 2014, Antalya.
E10. Kara C, Petriçli İS, Şekeroğlu MA, Hekimoğlu E. Intravitreal bevacizumab application as salvage therapy in patients with premature retinopathy unresponsive to laser therapy. Poster presentation. TOD 48th National Congress, 5-9 November 2014, Antalya.
E11. Petriçli İS, Kara C, Sekeroğlu MA, Hekimoğlu E, Çelebi ARC, Kavurt AS, Demirel N, Baş AY. A comparison of retinopathy during premature follow-up in infants with multiple and single pregnancies. Poster presentation. TOD 48th National Congress, 5-9 November 2014, Antalya.
E12. Şekeroğlu MA, Hekimoğlu E, Kara C, Çelik Ü, Kale Y, Baş AY. Premature retinopathy in triplets. Poster presentation. TOD 48th National Congress, 5-9 November 2014, Antalya.
E13. Şekeroğlu MA, Hekimoğlu E, Petriçli İS, Yücel H, Kavurt AS, Baş AY. Change in central corneal thickness measurements in preterm infants with increasing age. Poster presentation. TOD 48th National Congress, 5-9 November 2014, Antalya.
E14. Petriçli IS, Kara C, Hekimoğlu E, Sekeroğlu MA. Eight-year screening and treatment results of retinopathy of prematurity diagnostic and treatment centre. Oral presentation. 51st TOD National Congress 24-29 October 2017, Antalya, Turkey.
E15. Kara C, Petriçli IS, Hekimoğlu E, Sekeroğlu MA. Efficacy of intravitreal bevacizumab monotherapy in retinopathy of prematurity. Oral presentation. 51st TOD National Congress 24-29 October 2017, Antalya, Turkey